For the quarter ending 2025-09-30, LIDR had $32,769K increase in cash & cash equivalents over the period. -$20,299K in free cash flow.
| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -26,616 |
| Depreciation and amortization | 113 |
| Gain on sale of property and equipment, net | 0 |
| Noncash lease expense relating to operating lease right-of-use assets | 157 |
| Gain on termination of operating lease, net | 1,014 |
| Common stock purchase agreement costs | 325 |
| Debt issuance costs | 2,020 |
| Gain on extinguishment of warrant | 64 |
| Inventory write-downs, net of scrapped inventory | 24 |
| Change in fair value of convertible note and warrant liabilities | -2,123 |
| Stock-based compensation | 4,732 |
| Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest | 180 |
| Expected credit losses, net of write-off | 2 |
| Accounts receivable, net | 47 |
| Inventories, current and noncurrent, net | 523 |
| Prepaid and other current assets | -92 |
| Other noncurrent assets | -187 |
| Accounts payable | 800 |
| Accrued expenses and other current liabilities | -804 |
| Operating lease liabilities | -1,574 |
| Contract liabilities | 0 |
| Other noncurrent liabilities | 0 |
| Net cash used in operating activities | -20,247 |
| Purchases of property and equipment | 52 |
| Proceeds from sale of property and equipment | 0 |
| Purchases of marketable securities | 44,989 |
| Proceeds from redemptions and maturities of marketable securities | 15,874 |
| Net cash (used in) provided by investing activities | -29,167 |
| Proceeds from exercise of stock options | 0 |
| Proceeds from issuance of convertible note | 2,950 |
| Payments for convertible note redemptions | 989 |
| Transaction costs related to issuance of convertible note | 658 |
| Proceeds from issuance of common stock under common stock purchase agreements | 80,988 |
| Stock issuance costs related to common stock purchase agreements | 1,449 |
| Taxes paid related to the net share settlement of equity awards | 499 |
| Proceeds from exercise of warrant | 1,788 |
| Proceeds from issuance of common stock through the employee stock purchase plan | 52 |
| Net cash provided by financing activities | 82,183 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 32,769 |
| Cash and cash equivalents at beginning of period | 10,266 |
| Cash and cash equivalents at end of period | 43,035 |
AEye, Inc. (LIDR)
AEye, Inc. (LIDR)